
    
      The purpose of this study is to confirm the safety of low voltage external beam radiotherapy
      using the IRay System at two dose levels for the treatment of CNV secondary to neovascular
      AMD and to determine if the IRay System is effective in sparing the number of Lucentis
      injections during the first 12 months.
    
  